trial
as of 2026-07-01Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
NCTId NCT00498550
at a glance
Phase 4 · Completed
Enrollment 31 (actual)
Sponsored by Dartmouth-Hitchcock Medical Center
Primary completion 2009-03
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
31 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2000-10
Primary completion
2009-03
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Dartmouth-Hitchcock Medical CenterLead Sponsor
National Institute on Drug Abuse (NIDA)Collaborator
University of Missouri, Kansas CityCollaborator
VA Medical Center-West Los AngelesCollaborator
University of South CarolinaCollaborator
Investigators
1
Alan I. Green, MDPrincipal Investigator
Sites
4 total
Los Angeles, United StatesKansas City, United StatesManchester, United StatesColumbia, United States
Facts & assertions
4 sourced
Enrollment
31
Phase
PHASE4
Primary Completion Date
2009-03
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator
person